Many health tech investors think a Donald Trump presidency would be more favorable to the market, a new survey finds.
Why it matters: This comes despite Democratic nominee Kamala Harris' proposals to expand Medicare's benefits, which could be a boon to many health care businesses.
- Boutique investment bank Healthcare Growth Partners and Eliciting Insights surveyed 90 venture capital, growth equity and buyout investors. Of those surveyed, 27% are majority focused on health care IT.
Zoom out: When asked about private equity as a whole, 84% of respondents said Trump would have a more positive impact on investing, while 16% chose Harris.
Zoom in: The margin was narrower when it came to responses on health care investing specifically, with 64% of respondents favoring Trump, compared with 36% for Harris.
What they're saying: "This finding contrasts with the traditional expectation that Democratic candidates, who generally advocate for increased government spending and regulation, would be seen as more beneficial to health care operators," the report says.
The bottom line: The survey results reflect private equity's allergy to regulation.
